We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Shining Light on Farm & Food Policy for 20 Years.
Sunday, March 30, 2025
Warning letters sent by the Food and Drug Administration to 15 producers and sellers of CBD products show the agency is serious about enforcing current prohibitions on the marketing of goods containing cannabidiol, the non-psychoactive chemical contained in hemp.
CBD products are marketed almost everywhere these days, and hemp farmers are counting on this new, emerging market to bolster their revenues. However, the U.S. Food and Drug Administration (FDA) is stepping up its warnings on CBD in dietary supplements and food products
Nearly a year after the 2018 farm bill legalized industrial hemp production, the business community continues to seek answers to questions about testing and marketing of products derived from the crop, the commercial potential of which has sparked interest throughout the country.
USDA’s new hemp rule was generally well received by industry and states, but one longtime advocate is raising concerns that its testing requirements could create a logjam at harvest time.
The Agriculture Department released details Tuesday of a long-awaited regulatory process to guide states in the production and transportation of industrial hemp.
Hemp growers already facing a learning curve when it comes to producing the crop this year are confronting a scarier prospect than low yields or a lack of processing facilities: the potential for seizure of their crop on the road.
The Senate overwhelmingly approves a stopgap bill to keep the government funded through Nov. 21 and replenish the account that USDA relies on to make trade-assistance and commodity program payments.
The Senate is expected to clear a stopgap spending bill this week that will keep the government operating and trade-aid payments flowing to farmers after the new fiscal year begins Oct. 1.